Navigation Links
Kewaunee Scientific Reports Sales and Earnings for First Quarter
Date:8/24/2010

STATESVILLE, N.C., Aug. 24 /PRNewswire-FirstCall/ -- Kewaunee Scientific Corporation (Nasdaq: KEQU) today reported sales and earnings for its first quarter ended July 31, 2010.

Sales for the quarter were $24,858,000, down 5% from sales of $26,249,000 in the first quarter of the prior year. This was primarily the result of on-going softness in the domestic marketplace for small and mid-sized laboratory projects and the scheduled timing of shipments in the order backlog, partially offset by increased international sales. Domestic sales were $20,948,000, down from sales of $23,358,000 in the first quarter last year, while international sales increased to $3,910,000, up from $2,891,000 in the first quarter last year.  

Net earnings for the quarter were $657,000, or $0.25 per diluted share, down from net earnings of $1,071,000, or $0.42 per diluted share, in the first quarter of the prior year. Earnings were unfavorably impacted by the lower sales and continued aggressive pricing in all of the Company's markets.

The order backlog at the end of the quarter remained strong, both domestic and international.  The backlog was $66.9 million at July 31, 2010, up from $60.7 million at July 31, 2009 and down slightly from the record level of $68.9 million at April 30, 2010.

"Overall, the domestic marketplace for laboratory furniture continues to be healthy, although opportunities vary depending on the size of the project and geographic area," said Mr. Shumaker, President and Chief Executive Officer.  "Capital spending for larger laboratory projects continues to hold up relatively well, while funding and spending for small and mid-sized projects continues to be the most affected by the economic slowdown.  Capital spending for international laboratory projects appears to be recovering, as we have seen a significant increase in international sales opportunities over the past several months.

"Looking forward, our financial plan for fiscal year 2011 includes increased sales and earnings over the prior year, and we made good progress during the quarter on our operational plan," Mr. Shumaker continued. "We expect sales and earnings for the second quarter to improve over the first quarter, although below last year's strong second quarter results, followed by a stronger second half of the year. Our expectations are based on a number of factors, including scheduled delivery dates for orders in our order backlog, a partial recovery in the global economy, continuing increased sales opportunities for our products in the international marketplace, sales and earnings benefits from new products, and increased manufacturing capabilities in our Statesville and Bangalore facilities."

The Company's balance sheet remains strong.  Bank borrowings and capital lease obligations totaled $7.7 million at July 31, 2010, as compared to $6.6 million at July 31, 2009.  The debt-to-equity ratio was .24-to-1 at the end of the quarter, as compared to .22-to-1 at the end of the first quarter last year.  Cash on hand was $2.3 million at the end of the quarter, as compared to $3.5 million at the end of the first quarter last year.  Working capital was $18.9 million at July 31, 2010, as compared to $18.8 million at the end of the first quarter last year.  

Kewaunee Scientific Corporation is a recognized leader in the design, manufacture, and installation of scientific and technical furniture. The Company's corporate headquarters are located in Statesville, North Carolina.  The Company's manufacturing facilities are located in Statesville and Bangalore, India.  The Company has subsidiaries in Singapore and Bangalore that serve the Asian and Middle East markets.  Kewaunee Scientific's website is located at http://www.kewaunee.com

Certain statements in this release constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that could significantly impact results or achievements expressed or implied by such forward-looking statements. These factors include, but are not limited to, economic, competitive, governmental, and technological factors affecting the Company's operations, markets, products, services, and prices.Consolidated Statements of Operations [unaudited]
(in thousands, except per share data)Three Months EndedJuly 31

July 312010

2009Net sales

$24,858

$26,249Cost of products sold

19,859

20,485Gross profit

4,999

5,764Operating expenses

3,901

3,966Operating earnings

1,098

1,798Interest expense

(45)

(41)Earnings before income taxes

1,053

1,757Income tax expense

329

589Net earnings

724

1,168Less: net earnings attributable tothe noncontrolling interest

(67)

(97)Net earnings attributable toKewaunee Scientific Corporation

$657

$1,071Net earnings per share attributable toKewaunee Scientific Corporation stockholdersBasic

$0.26

$0.42Diluted

$0.25

$0.42Weighted average number of commonshares outstandingBasic

2,573

2,556Diluted

2,578

2,558Condensed Consolidated Balance Sheets
(in thousands)July 31

April 302010

2010Assets

[unaudited]Cash and cash equivalents

$1,812

$1,722Restricted cash

521

544Receivables, less allowances

27,425

26,169Inventories

8,226

8,350Prepaid expenses and other current assets

1,761

1,797   Total Current Assets

39,745

38,582Net property, plant and equipment

15,405

13,815Other assets

4,230

4,224Total Assets

$59,380

$56,621Liabilities and Stockholders' EquityShort-term borrowings

$7,496

$4,872Current obligations under capital leases

78

82Accounts payable

9,046

9,540Other current liabilities

4,184

4,003   Total Current Liabilities

20,804

18,497Other non-current liabilities

6,563

6,452   Total Liabilities

27,367

24,949Noncontrolling interest

1,273

1,239Kewaunee Scientific Corporation equity

30,740

30,433   Total Equity

32,013

31,672Total Liabilities and Equity

$59,380

$56,621Contact:

D. Michael Parker704/871-3290
'/>"/>

SOURCE Kewaunee Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
2. Medco Announces Agreement to Acquire United BioSource Corporation: A Global Medical Research and Scientific Services Leader to Advance Drug Safety and Knowledge
3. Tolerx Appoints Antonin de Fougerolles, Ph.D., as Chief Scientific Officer
4. Derycz Scientific CEO Named to PharmaVoice 100 for 2010
5. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
6. QRxPharma Receives Positive Feedback from Scientific Advice Meetings in Europe on MoxDuo®IR Development and Registration
7. Rcadia Announces Five COR Analyzer® Studies to be Presented at SCCT Annual Scientific Meeting
8. InteRNA Technologies Announces Establishment of Scientific Advisory Board
9. NeoStem Adds Distinguished Researcher to its World-Class Scientific Advisory Board
10. Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity From Its Broad Metabolic Disease Franchise at ADA Scientific Sessions
11. Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016 Jazz Pharmaceuticals ... waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of ... acquisition of Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: ... p.m. (Eastern Daylight Time). As previously announced ... into a definitive merger agreement under which Jazz Pharmaceuticals ...
(Date:6/24/2016)... SOUTH SAN FRANCISCO, Calif. , June 24, ... GBT ), a biopharmaceutical company developing novel ... with significant unmet needs, today announced the closing ... 6,400,000 shares of common stock, at the public ... the shares in the offering were offered by ...
(Date:6/24/2016)... June 24, 2016 Dehaier Medical Systems Ltd. ... which develops, markets and sells medical devices and wearable ... signed a strategic cooperation agreement with Hongyuan Supply Chain ... Chain") on June 20, 2016, to develop Dehaier,s new ... cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s sales ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. In ... benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued ... Sickle Cell Disease (SCD) is a disorder of the red blood cells, which can ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are recognized ... this recognition are considered among the top 2 percent of lawyers practicing within the ... this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, Burt ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):